Cargando…
MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation
Inhibition of the interaction between MDM2 and p53 has emerged as a promising strategy for combating cancer, including the treatment of glioblastoma (GBM). Numerous MDM2 inhibitors have been developed and are currently undergoing rigorous testing for their potential in GBM therapy. Encouraging resul...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377337/ https://www.ncbi.nlm.nih.gov/pubmed/37509518 http://dx.doi.org/10.3390/biomedicines11071879 |